Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Rik Ossenkoppele(Malmö University), Oskar Hansson(Eli Lilly (United States)), Reisa A. Sperling(Harvard University), Clifford R. Jack(Mayo Clinic), Tomas Ohlsson(Skåne University Hospital), Alexa Pichet Binette(Lund University), Christopher C. Rowe(The University of Melbourne), Sebastian Palmqvist(Skåne University Hospital), Erik Stomrud(Lund University), Denise Visser(University Medical Center Utrecht), Pontus Tideman(Lund University), Olof Strandberg(Lund University), Wiesje M. van der Flier(Amsterdam Neuroscience), Ruben Smith(Lund University), Ronald C. Petersen(Mayo Clinic in Arizona), Colin L. Masters(Mental Health Research Institute), Colin Groot(Amsterdam Neuroscience), William J. Jagust(Lawrence Berkeley National Laboratory), Suzanne L. Baker(University of California, Berkeley), Keith A. Johnson(Brigham and Women's Hospital), Bart N. M. van Berckel(Amsterdam Neuroscience), Jonas Jögi(Skåne University Hospital), Heather J. Wiste(Mayo Clinic in Florida), Vincent Doré(Australian e-Health Research Centre)
Cited by 483
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k